Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (31-40 of 368) with videos related to

Pageof 37
Sort By:
The International Journal on Drug Policy|October 15, 2020
Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementationAlison D Marshall, Max Hopwood, Jason Grebely, et al.
Drug and Alcohol Dependence|August 13, 2013
Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, AustraliaCarla Treloar, Jake Rance, Jason Grebely, et al.
The International Journal on Drug Policy|July 5, 2017
'I didn't want to let it go too far.' The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife studyAlison D Marshall, Jason Grebely, Gregory J Dore, et al.
Infectious Disease Clinics of North America|May 21, 2018
Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject DrugsMarianne Martinello, Gregory J Dore, Gail V Matthews, et al.
Journal of Addictive Diseases|August 7, 2008
Current approaches to HCV infection in current and former injection drug usersJason Grebely, Stanley deVlaming, Fiona Duncan, et al.
The Journal of Infectious Diseases|February 8, 2013
Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levelsJason Grebely, Megan Oser, Lynn E Taylor, et al.
Expert Review of Molecular Diagnostics|November 2, 2017
Hepatitis C point-of-care diagnostics: in search of a single visit diagnosisJason Grebely, Tanya L Applegate, Philip Cunningham, et al.
Journal of the Royal Society, Interface|January 16, 2015
Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study dataRachel Sacks-Davis, Emma McBryde, Jason Grebely, et al.
Drug and Alcohol Review|September 2, 2022
People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative studyAnna Conway, Carla Treloar, Sione Crawford, et al.
The International Journal on Drug Policy|July 27, 2019
Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for allJason Grebely, Behzad Hajarizadeh, Jeffrey V Lazarus, et al.
Pageof 37

Showing results (31-40 of 368) with videos related to

Sort By:
Pageof 37
The International Journal on Drug Policy|October 15, 2020
Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementationAlison D Marshall, Max Hopwood, Jason Grebely, et al.
Drug and Alcohol Dependence|August 13, 2013
Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, AustraliaCarla Treloar, Jake Rance, Jason Grebely, et al.
The International Journal on Drug Policy|July 5, 2017
'I didn't want to let it go too far.' The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife studyAlison D Marshall, Jason Grebely, Gregory J Dore, et al.
Infectious Disease Clinics of North America|May 21, 2018
Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject DrugsMarianne Martinello, Gregory J Dore, Gail V Matthews, et al.
Journal of Addictive Diseases|August 7, 2008
Current approaches to HCV infection in current and former injection drug usersJason Grebely, Stanley deVlaming, Fiona Duncan, et al.
The Journal of Infectious Diseases|February 8, 2013
Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levelsJason Grebely, Megan Oser, Lynn E Taylor, et al.
Expert Review of Molecular Diagnostics|November 2, 2017
Hepatitis C point-of-care diagnostics: in search of a single visit diagnosisJason Grebely, Tanya L Applegate, Philip Cunningham, et al.
Journal of the Royal Society, Interface|January 16, 2015
Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study dataRachel Sacks-Davis, Emma McBryde, Jason Grebely, et al.
Drug and Alcohol Review|September 2, 2022
People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative studyAnna Conway, Carla Treloar, Sione Crawford, et al.
The International Journal on Drug Policy|July 27, 2019
Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for allJason Grebely, Behzad Hajarizadeh, Jeffrey V Lazarus, et al.
Pageof 37